9 citations
,
September 2022 in “Journal of Clinical Investigation” Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.
56 citations
,
February 2010 in “PLOS ONE” Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.
1 citations
,
August 2025 in “Journal of Human Immunity” The study investigates the effects of minoxidil on thymic growth in mouse models of 22q11.2 deletion syndrome (22q11.2DS), which causes thymic hypoplasia, hypoparathyroidism, and cardiac defects. Researchers found that embryonic thymuses in these models have an expansion of Sox9+ chondrocytes, affecting thymus size and vascularization. Administering minoxidil to pregnant mice before thymic development restored thymic growth and corrected mesenchymal and endothelial dysregulation. This was evidenced by reduced expression of Sox9-driven cartilaginous collagens and corrected parathyroid location. The findings suggest that targeting prenatal mesenchymal differentiation can address multiple congenital anomalies in 22q11.2DS mouse models.
5 citations
,
January 2022 in “PloS one” Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.
69 citations
,
January 2013 in “Frontiers in Immunology” The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.